| Companies sponsors |
Johnson & Johnson (talquetamab) |
| Others |
Department of Health and Social Care |
| |
NHS England |
| Patient carer groups |
Blood Cancer UK |
| |
Myeloma UK |
| Professional groups |
Association of Cancer Physicians |
| |
Cancer Research UK |
| |
Royal College of Pathologists |
| |
Royal College of Physicians |
| |
Royal College of Radiologists |
| |
UK Myeloma Society |
| Associated public health groups |
None |
| Comparator companies |
GlaxoSmithKline (belantamab) (confidentiality agreement signed, participating) |
| |
Menarini Stemline (selinexor) (confidentiality agreement signed, participating) |
| |
Pfizer (bortezomib) (confidentiality agreement signed, participating) |
| |
Sanofi (isatuximab) (confidentiality agreement signed, participating) |
| |
Aspire Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Aurobindo Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Biotech Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Bristol Myers Squibb (pomalidomide) (confidentiality agreement not signed, not participating) |
| |
Dr Reddy’s Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Johnson & Johnson (bortezomib, teclistamab) (confidentiality agreement not signed, not participating) |
| |
MSN Laboratories Europe (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Pharmaand GmbH (panobinostat) (confidentiality agreement not signed, not participating) (confidentiality agreement not signed, not participating) |
| |
Sandoz (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Sun Pharma (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Thornton and Ross (bortezomib) (confidentiality agreement not signed, not participating) |
| |
Tillomed Laboratories (bortezomib) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
NHS Wales Joint Commissioning Committee |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| Relevant research groups |
Institute of Cancer Research |